Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives

被引:130
作者
Coppola, Marco Morelli [1 ]
Salzillo, Rosa [1 ]
Segreto, Francesco [1 ]
Persichetti, Paolo [1 ]
机构
[1] Campus Biomed Univ Rome, Dept Plast Reconstruct & Aesthet Surg, Via Alvaro del Portillo 21, I-00128 Rome, Italy
关键词
keloids; scars; intralesional corticosteroid injections; CUSHINGS-SYNDROME SECONDARY; ENDOTHELIAL GROWTH-FACTOR; DIOXIDE LASER EXCISION; HYPERTROPHIC SCARS; EARLOBE KELOIDS; DERMAL FIBROBLASTS; COLLAGEN-SYNTHESIS; TREATING KELOIDS; CLINICAL-TRIAL; FACTOR-BETA;
D O I
10.2147/CCID.S133672
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keloids are pathological scars presenting as nodular lesions that extend beyond the area of injury. They do not spontaneously regress, often continuing to grow over time. The abnormal wound-healing process underlying keloid formation results from the lack of control mechanisms self-regulating cell proliferation and tissue repair. Keloids may lead to cosmetic disfigurement and functional impairment and affect the quality of life. Although several treatments were reported in the literature, no universally effective therapy was found to date. The most common approach is intralesional corticosteroid injection alone or in combination with other treatment modalities. Triamcinolone acetonide (TAC) is the most commonly used intralesional corticosteroid. The aim of this article was to review the use of TAC, alone or in combination, in the treatment of keloid scars. The response to corticosteroid injection alone is variable with 50-100% regression and a recurrence rate of 33% and 50% after 1 and 5 years, respectively. Compared to verapamil, TAC showed a faster and more effective response even though with a higher complication rate. TAC combined with verapamil was proved to be effective with statistically significant overall improvements of scars over time and long-term stable results. TAC and 5-fluorouracil (5-FU) intralesional injections were found to achieve comparable outcomes when administered alone, although 5-FU was more frequently associated with side effects. Conversely, the combination of 5-FU and TAC was more effective and showed fewer undesirable effects compared to TAC or 5-FU alone. Several kinds of laser treatments were reported to address keloids; however, laser therapy alone was burdened with a high recurrence rate. Better results were described by combining CO2, pulsed-dye or Nd: YAG lasers with TAC intralesional injections. Further options such as needle-less intraepidermal drug delivery are being explored, but more studies are needed to establish safety, feasibility and effectiveness of this approach.
引用
收藏
页码:387 / 396
页数:10
相关论文
共 87 条
[1]   Effectiveness of Intralesional Triamcinolone in the Treatment of Keloids in Children [J].
Acosta, Silvana ;
Ureta, Ester ;
Yanez, Ricardo ;
Oliva, Natalia ;
Searle, Susana ;
Guerra, Claudio .
PEDIATRIC DERMATOLOGY, 2016, 33 (01) :75-79
[2]   Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids [J].
Ahuja, Rajeev B. ;
Chatterjee, Pallab .
BURNS, 2014, 40 (04) :583-588
[3]   Keloid and hypertrophic medical hypotheses scar: Neurogenic inflammation hypotheses [J].
Akaishi, Satoshi ;
Ogawa, Rei ;
Hyakusoku, Hiko .
MEDICAL HYPOTHESES, 2008, 71 (01) :32-38
[4]   Combination of different techniques for the treatment of earlobe Keloids [J].
Aköz, T ;
Gideroglu, K ;
Akan, M .
AESTHETIC PLASTIC SURGERY, 2002, 26 (03) :184-188
[5]   Keloid pathogenesis and treatment [J].
Al-Attar, A ;
Mess, S ;
Thomassen, JM ;
Kauffman, CL ;
Davison, SP .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (01) :286-300
[6]   FAILURE OF CARBON-DIOXIDE LASER EXCISION OF KELOIDS [J].
APFELBERG, DB ;
MASER, MR ;
WHITE, DN ;
LASH, H .
LASERS IN SURGERY AND MEDICINE, 1989, 9 (04) :382-388
[7]  
Apikian Martine, 2004, Australas J Dermatol, V45, P140, DOI 10.1111/j.1440-0960.2004.00072.x
[8]   CHANGES IN TYPE-I COLLAGEN FOLLOWING LASER-WELDING [J].
BASS, LS ;
MOAZAMI, N ;
POCSIDIO, J ;
OZ, MC ;
LOGERFO, P ;
TREAT, MR .
LASERS IN SURGERY AND MEDICINE, 1992, 12 (05) :500-505
[9]   'Aggressive keloid': a severe variant of familial keloid scarring [J].
Bayat, A ;
Arscott, G ;
Ollier, WER ;
Ferguson, MWJ ;
McGrouther, DA .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2003, 96 (11) :554-555
[10]   SELECTION OF THERAPEUTIC AGENTS FOR INTRAOCULAR PROLIFERATIVE DISEASE - CELL-CULTURE EVALUATION [J].
BLUMENKRANZ, MS ;
CLAFLIN, A ;
HAJEK, AS .
ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (04) :598-604